As UnitedHealth racks up unprecedented profits, the people it insures battle for care.
CMS
Posted inHealth and Social Policy
Company Behind Joe Namath Medicare Advantage Ads Has Long Rap Sheet of Misconduct
The firm formerly known as Benefytt pocketed millions selling sham insurance to seniors and other consumers.
Posted inHealth and Social Policy
The Great Medicare Advantage Marketing Scam
How for-profit health insurers convince seniors to enroll in private Medicare plans
Posted inMoney, Politics, and Power
Democrats Could Score Big by Blocking This Revolver
Demetrios Kouzoukas’s nomination battle offers the perfect opportunity for Democrats to prove themselves to voters.
Posted inHealth and Social Policy
The Medicare Advantage Trap
In 46 states, once you choose Medicare Advantage at 65, you can almost never leave.
Posted inHealth and Social Policy
We May Not Negotiate Prices for Ten Drugs After All
Rules that exempt drugs from Medicare negotiation if there’s ‘meaningful’ generic competition could whittle down the effect of the program.
Posted inHealth and Social Policy
Medicare Price Negotiation: Ten Drugs That Made the List, and Ten That Should Have
Advocates were thrilled that Medicare will negotiate the price of several insulins. But other high-profit drugs are protected by the new program’s rules.
Posted inHealth and Social Policy
Patient Zero
Tom Scully is as responsible as anyone for the way health care in America works today.
Posted inHealth and Social Policy
Regulators on the Verge of Bungling Drug Price Reform, Advocates Say
The starting point for negotiations with drug companies on prescription prices could end up being the too-high prices patients already live with.
Posted inHealth and Social Policy
Born to Die
Medicare spends tens of billions of dollars on hospice care each year. A new report ponders why regulators insist on going easy on literal death merchants.
